138 related articles for article (PubMed ID: 9274905)
1. Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.
Castiella A; Iribarren JA; López P; Arrizabalaga J; Rodríguez F; von Wichmann MA; Arenas JI
Am J Med; 1997 Aug; 103(2):170-1. PubMed ID: 9274905
[No Abstract] [Full Text] [Related]
2. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
3. Favourable long term effect of ursodeoxycholic acid treatment on congenital vanishing bile duct syndromes.
Karageorgos SA; Tzardi M; Stratakou S; Voumvouraki A; Notas G; Kouroumalis E
Acta Gastroenterol Belg; 2018; 81(2):330-332. PubMed ID: 30024707
[No Abstract] [Full Text] [Related]
4. Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien CB; Shields DS; Saul SH; Reddy KR
Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
[No Abstract] [Full Text] [Related]
5. [Diseases of the intrahepatic bile duct: diagnosis and principles of treatment].
Chazouillères O; Wendum D
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):307-18. PubMed ID: 12700519
[No Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study.
Berkhout M; Roelofs HM; Friederich P; van Schaik A; Gosens MJ; Marian B; Pool-Zobel BL; van Krieken JH; Peters WH; Nagengast FM
Transl Res; 2007 Sep; 150(3):147-9. PubMed ID: 17761365
[No Abstract] [Full Text] [Related]
8. Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab.
Reddy CA; Schneider BJ; Brackett LM; Tai AW
Immunotherapy; 2019 Dec; 11(18):1527-1531. PubMed ID: 31789069
[TBL] [Abstract][Full Text] [Related]
9. Biliary microlithiasis.
Menon S
Gastrointest Endosc; 2009 May; 69(6):1197-8; author reply 1198. PubMed ID: 19410059
[No Abstract] [Full Text] [Related]
10. [Hepatobiliary disease in cystic fibrosis].
Pérez-Aguilar F; Berenguer Lapuerta J
Med Clin (Barc); 1998 Sep; 111(8):302-6. PubMed ID: 9810550
[No Abstract] [Full Text] [Related]
11. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
Jain P
J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
[No Abstract] [Full Text] [Related]
12. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
Christensen KL; Andersen BN; Vilstrup H
Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of intrahepatic lithiasis].
Ponchon T
Gastroenterol Clin Biol; 2001; 25(6-7):577-9. PubMed ID: 11673725
[No Abstract] [Full Text] [Related]
14. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
15. [Intrahepatic cholestasis of pregnancy. New treatment].
Ranek L; Ott P
Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
[No Abstract] [Full Text] [Related]
16. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya P; Lindor KD
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
[No Abstract] [Full Text] [Related]
17. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
18. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
Kondrackiene J; Beuers U; Kupcinskas L
Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
[TBL] [Abstract][Full Text] [Related]
20. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
